Majchrzak-Celińska, A.; Kleszcz, R.; Studzińska-Sroka, E.; Łukaszyk, A.; Szoszkiewicz, A.; Stelcer, E.; Jopek, K.; Rucinski, M.; Cielecka-Piontek, J.; Krajka-Kuźniak, V.
Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells 2022, 11, 1084.
https://doi.org/10.3390/cells11071084
AMA Style
Majchrzak-Celińska A, Kleszcz R, Studzińska-Sroka E, Łukaszyk A, Szoszkiewicz A, Stelcer E, Jopek K, Rucinski M, Cielecka-Piontek J, Krajka-Kuźniak V.
Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells. 2022; 11(7):1084.
https://doi.org/10.3390/cells11071084
Chicago/Turabian Style
Majchrzak-Celińska, Aleksandra, Robert Kleszcz, Elżbieta Studzińska-Sroka, Agnieszka Łukaszyk, Anna Szoszkiewicz, Ewelina Stelcer, Karol Jopek, Marcin Rucinski, Judyta Cielecka-Piontek, and Violetta Krajka-Kuźniak.
2022. "Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide" Cells 11, no. 7: 1084.
https://doi.org/10.3390/cells11071084
APA Style
Majchrzak-Celińska, A., Kleszcz, R., Studzińska-Sroka, E., Łukaszyk, A., Szoszkiewicz, A., Stelcer, E., Jopek, K., Rucinski, M., Cielecka-Piontek, J., & Krajka-Kuźniak, V.
(2022). Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells, 11(7), 1084.
https://doi.org/10.3390/cells11071084